Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $1.97 Million - $2.5 Million
7,270 New
7,270 $2.5 Million
Q3 2022

Nov 14, 2022

SELL
$120.36 - $205.88 $1.29 Million - $2.21 Million
-10,731 Reduced 29.7%
25,400 $4.82 Million
Q2 2022

Aug 15, 2022

BUY
$116.09 - $227.33 $4.19 Million - $8.21 Million
36,131 New
36,131 $4.5 Million
Q1 2022

May 16, 2022

SELL
$187.51 - $283.98 $29.9 Million - $45.2 Million
-159,200 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$238.08 - $288.0 $15.2 Million - $18.4 Million
-63,902 Reduced 28.64%
159,200 $45.7 Million
Q3 2021

Nov 15, 2021

BUY
$250.72 - $291.24 $47.3 Million - $54.9 Million
188,676 Added 548.06%
223,102 $59.5 Million
Q2 2021

Aug 16, 2021

BUY
$235.0 - $310.7 $53,110 - $70,218
226 Added 0.66%
34,426 $9.44 Million
Q1 2021

May 17, 2021

BUY
$175.6 - $291.43 $6.01 Million - $9.97 Million
34,200 New
34,200 $9.25 Million
Q1 2020

May 15, 2020

SELL
$124.34 - $193.76 $15.3 Million - $23.8 Million
-122,959 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$134.81 - $177.8 $3.77 Million - $4.98 Million
-27,991 Reduced 18.54%
122,959 $20.2 Million
Q3 2019

Nov 15, 2019

BUY
$131.82 - $183.4 $19.9 Million - $27.7 Million
150,950 New
150,950 $20.3 Million
Q2 2019

Aug 14, 2019

SELL
$124.65 - $167.39 $1.14 Million - $1.54 Million
-9,180 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$115.84 - $160.31 $1.06 Million - $1.47 Million
9,180 New
9,180 $1.35 Million
Q2 2018

Aug 14, 2018

SELL
$112.2 - $165.95 $3.37 Million - $4.98 Million
-30,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$84.6 - $126.1 $2.54 Million - $3.78 Million
30,000 New
30,000 $3.47 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.